Flex LNG – Ex dividend USD 0.75 today
The shares in Flex LNG Ltd. will be traded ex dividend USD 0.75 as from today, 01.12.2021.
Year: 2021
Corbion successfully completes subordinated US Private Placement of € 100 million
Corbion has succesfully placed subordinated US Private Placement (USPP) Notes with 4 institutional investors. The issuance of €100 million consists of two tranches, €16 million at a fixed coupon rate of 1.77% and €84 million at a fixed coupon rate of 2.01% with maturities of 5 and 7 years, respectively.
The proceeds will be used to repay borrowings under the current € 300 million Revolving Credit Facility and for general corporate purposes. This program will further optimise the maturity profile of Corbion’s outstanding debt.Attachment20211201 USPP_SubordNotes ENG
Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy
Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapyOrigimm brings expertise in antigen discovery for immune modulation of skin microbiome-associated disorders
Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide
Sanofi to leverage its next-generation mRNA platform to unlock potential of vaccine-candidatePARIS and VIENNA – December 1, 2021 – Sanofi announced today it entered into an agreement to acquire Origimm Biotechnology GmbH, an Austrian privately owned biotechnology company specializing in the discovery of virulent skin microbiome components and antigens from bacteria causing skin disease, such as acne. With this acquisition, Sanofi continues executing its global Play to Win...
Roche completes purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseases
TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the COVID-19 pandemic
The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use assays on Roche’s LightCycler PCR instruments
TIB Molbiol will continue to focus on the research and development of assays that rapidly address critical healthcare needs including biological threatsBasel, 1 December 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has completed its share purchase agreement to acquire 100 percent of the outstanding shares of TIB Molbiol Group. TIB Molbiol will continue to operate as a subsidiary within the Diagnostics division. Roche and TIB Molbiol will build on their capabilities for the rapid development of assays for emerging...
ForFarmers N.V.: ForFarmers decides to start share-buyback programme
Lochem, 1 December 2021
ForFarmers decides to start share-buyback programme
ForFarmers announces to start a programme to repurchase its own shares (share-buyback programme, SBB) for a maximum amount of €50 million, amongst others to make the balance sheet more efficient (share capital reduction). This is in line with the release issued by the Company on 2 November last, in which it announced to disclose its plans on an alternative capital allocation, besides the then also announced intention to distribute a dividend per ordinary share over 2021, which is comparable to the dividend over 2020.
For the SBB programme, ForFarmers will use the authorisation given by the General Meeting of Shareholders on 23 April 2021 to repurchase at maximum 10% of its own shares and, if granted, the authorisation of the Annual General Meeting in...
Array Technologies, Inc. Announces Pricing of Upsized Convertible Senior Notes Offering
ALBUQUERQUE, N.M., Nov. 30, 2021 (GLOBE NEWSWIRE) — Array Technologies, Inc. (NASDAQ: ARRY) (the “Company” or “Array”) today announced it has priced an upsized offering of $375 million aggregate principal amount of 1.00% convertible senior notes due 2028 (the “notes”) in a private offering (the “offering”) to eligible purchasers under Rule 144A of the Securities Act of 1933, as amended (the “Securities Act”). Array expects the offering to close on December 3, 2021, subject to the satisfaction of customary closing conditions. The additional proceeds from upsized offering will enable the Company to reduce the amount of Series A Preferred Stock that the Company intends to issue to finance a portion of the cash consideration for the STI Acquisition (as defined below) from $100 million to $50.0 million. The reduction will result in...
MedMira Reports FY2021 Fourth Quarter and Year End Financial Results
HALIFAX, Nova Scotia, Nov. 30, 2021 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the financial year ended July 31, 2021.
Profit and Loss HighlightsRevenue: The Company recorded revenues in FY2021 of $2,060,497 compared to $588,836 in FY2020. The increase in revenue was due to the Company’s additional revenues generated with the REVEALCOVID-19TM Total Antibody Test.
Gross Profit: The Company recorded a gross profit in FY2021 of $1,716,789 compared to $371,220 for the same period last year.
Operating expenses: In this financial year, the Company recorded operating expenses of $1,905,974 compared to $1,872,437 in FY2020. The increase of approximately 2% in operating expenses were due to additional labour costs associated with the enhanced production for the Company’s REVEALCOVID-19TM...
SmartCentres Doubles Ownership in SmartVMC City Centre, Becomes Largest Landowner in the Vaughan Metropolitan Centre. SmartLiving Set to Grow.
TORONTO, Nov. 30, 2021 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres” or the “REIT”) (TSX:SRU.UN), announces a $513 million strategic acquisition of a two-thirds interest in 53 acres (“Acquired Lands”), in ‘SmartVMC’, the 100+ acre master-planned City Centre in the Vaughan Metropolitan Centre. This more than doubles SmartCentres’ interest in SmartVMC, uniting ownership across the property and making SmartCentres the largest landowner in Vaughan’s dynamic TTC subway-connected Downtown.
“These 53 acres represent the most strategic property in the country for SmartCentres REIT,” said Mitchell Goldhar, Executive Chairman and CEO of SmartCentres. “With 45,000 people expected to ultimately call SmartVMC home, it is the jewel in the crown of SmartCentres’ portfolio.”
The Acquired Lands have in-place Permissions...
Krystal Biotech Announces Pricing of $200 Million Public Offering of Common Stock
PITTSBURGH, Nov. 30, 2021 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (NASDAQ: KRYS) (the “Company”), the leader in redosable gene therapies for rare diseases, today announced that it has priced the previously announced underwritten public offering of 2,666,667 shares of its common stock, at a public offering price of $75.00 per share. The Company and certain selling stockholders granted the underwriters a 30-day option to purchase up to an additional 400,000 shares of the Company’s common stock offered in the public offering. The gross proceeds to the Company from this offering are expected to be approximately $200 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. All of the shares to be sold in the proposed offering will be sold by the Company other...
Arisz Acquisition Corp. Announces the Separate Trading of its Common Stock, Rights and Warrants, Commencing December 9, 2021
NEW YORK, Nov. 30, 2021 (GLOBE NEWSWIRE) — Arisz Acquisition Corp. (“ARIZ”) announced today that, commencing December 9, 2021, holders of the units sold in the Company’s initial public offering completed on November 22, 2021 may elect to separately trade the shares of common stock of ARIZ, and the rights and warrants included in such units on The Nasdaq Global Market (“Nasdaq”).The shares of common stock, rights and warrants that are separated will trade on NASDAQ under the symbols “ARIZ,” “ARIZR” and “ARIZW,” respectively. Those units not separated will continue to trade on Nasdaq under the symbol “ARIZU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, ARIZ’s transfer agent, in order to separate the units into shares of common stock, rights and warrants.The units were...
